Search research articles
Contact Us
Filters
Showing results (331-340 of 402) with videos related to
Page
of 41
Sort By:
Mbio
|
June 2, 2016
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells
Kellie N Smith, Robbie B Mailliard, Paolo A Piazza, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
December 10, 2015
Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach
Engi A Hassaan, Sara C Sigler, Tamer M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
November 3, 2012
Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives
Nermin S Ahmed, Amal H Ali, Shreen M El-Nashar, et al.
Oncogene
|
January 31, 2012
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs
X Li, L Gao, Q Cui, et al.
Medcomm
|
October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
Antonio B Ward, Adam B Keeton, Xi Chen, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents
Ismail Salama, Mohamed A O Abdel-Fattah, Marwa S Hany, et al.
American Heart Journal
|
May 29, 2000
Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up
E Brscic, S Bergerone, A Gagnor, et al.
Bioorganic Chemistry
|
March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors
Ahmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry
|
November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors
Mohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 402) with videos related to
Sort By:
Page
of 41
Mbio
|
June 2, 2016
Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells
Kellie N Smith, Robbie B Mailliard, Paolo A Piazza, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
December 10, 2015
Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach
Engi A Hassaan, Sara C Sigler, Tamer M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
November 3, 2012
Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives
Nermin S Ahmed, Amal H Ali, Shreen M El-Nashar, et al.
Oncogene
|
January 31, 2012
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs
X Li, L Gao, Q Cui, et al.
Medcomm
|
October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
Antonio B Ward, Adam B Keeton, Xi Chen, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents
Ismail Salama, Mohamed A O Abdel-Fattah, Marwa S Hany, et al.
American Heart Journal
|
May 29, 2000
Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up
E Brscic, S Bergerone, A Gagnor, et al.
Bioorganic Chemistry
|
March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors
Ahmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry
|
November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors
Mohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.
Page
of 41